Glass House Brands (GLAS) Treasury Shares (2022 - 2025)
Glass House Brands (GLAS) posted quarterly Treasury Shares of $49969.0 for Q4 2024, little changed quarter-over-quarter from $49969.0 in Q4 2022.
Glass House Brands (GLAS) Treasury Shares (2022 - 2025) Analysis & Trends
Glass House Brands (GLAS) has reported Treasury Shares for 2 consecutive years, with $49969.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Treasury Shares changed N/A year-over-year to $49969.0; the TTM figure through Dec 2024 stood at $49969.0 (changed N/A YoY), while the FY2025 annual figure was $5.3 million, up 59.76% from the prior year.
- Treasury Shares steadied at $49969.0 in Q4 2024 per GLAS's latest filing, from $49969.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $49969.0 in Q4 2022 and bottomed at $49969.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.33 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Dec 31, 2024 | 49,969.00 |
| Dec 31, 2024 | 49,969.00 |
| Dec 31, 2022 | 49,969.00 |
| Dec 31, 2022 | 49,969.00 |